Explain this page
Arphra AIPlain-English read on Insmed Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for INSM.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.82% | -1.64% | -20.43% | -29.00% | -49.85% | -39.08% | +47.92% | +451.09% | +321.26% | +791.76% | -35.74% |
Aftermarket
LiveLast trade
$106.04
10 sh
Bid
$106.03
100 sh
Ask
$107.00
424 sh
Spread
$0.970
Sector & industry today
LiveSectors
- Technology+0.67%
- Basic Materials+0.15%
- Communication Services+0.13%
- Real Estate-0.13%
- Industrials-0.48%
- Energy-0.58%
- Healthcare-0.65%
- Financial Services-0.80%
- Consumer Defensive-0.85%
- Consumer Cyclical-0.85%
- Utilities-1.15%
Top industries (issuer's industry highlighted)
- Biotechnology+3.22%
- Computer Hardware+8.35%
- Software - Infrastructure+7.61%
- Coal+5.76%
- Consulting Services+5.28%
- Medical - Healthcare Information Services+5.23%
- Medical - Diagnostics & Research+4.96%
- REIT - Healthcare Facilities-3.49%
- Broadcasting-3.48%
- Software - Application+3.44%
- Advertising Agencies+3.24%
- Travel Services+3.21%
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $213.11 (+100.99%)
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Insmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Insmed Reports First-Quarter 2026 Financial Results and Provides Business Updateprnewswire.com·May 07, 2026
- Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasisprnewswire.com·May 06, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|